86 citations
,
July 2002 in “Clinical and Experimental Dermatology”
This review discusses female pattern hairloss, emphasizing its complex causes and the limited treatment options available, and reports no new clinical results.
1 citations
,
May 2020 in “Reproductive Endocrinology”
This review discusses the pathogenesis and diagnosis of alopecia and acne, emphasizing the need for coordinated treatment approaches in conditions like FPHL/AGA and complex acne, but reports no new clinical results.
January 2020 in “Journal of clinical and cosmetic dermatology”
This article reviews the etiology of FPHL, distinguishing between androgen-dependent and androgen-independent forms, but reports no new clinical findings; it highlights the need to better understand its pathogenesis.
This article reviews the anatomy and pathology of skin and hair to aid in diagnosing skin diseases and discusses potential therapies, without reporting new clinical results.
Hairloss may be linked to the GPR133 receptor, independent of the androgen receptor pathway. Treatments like finasteride, dutasteride, minoxidil, RU58841, and KX-826 show varying results, with hairloss persisting due to high testosterone and GPR133's role.
Sugary beverages increase the risk of pattern hairloss in men by 57%, and type 2 diabetes is linked to female pattern hairloss. Reducing sugar intake and using treatments like finasteride and minoxidil may help manage hairloss.
Eucapil is discussed as a potential hairloss treatment with some believing it to be effective, though its efficacy compared to finasteride is debated. It is considered an anti-androgen treatment, often used alongside other treatments like minoxidil and finasteride, but lacks independent studies to fully support its effectiveness.
New hairloss treatments include Breezula, PP405, ET-02, KX-826, GT20029, VDPHL01, and CosmeRNA, with some showing promise in reactivating stem cells and reversing greying. Breezula and VDPHL01 are highlighted as potential add-ons or alternatives to current treatments like finasteride and minoxidil.